Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$285.76 - $321.48 $393,205 - $442,356
1,376 New
1,376 $397,000
Q2 2022

Aug 16, 2022

SELL
$234.96 - $292.55 $55,920 - $69,626
-238 Reduced 8.7%
2,499 $704,000
Q1 2022

Feb 08, 2024

BUY
$221.42 - $260.97 $584,105 - $688,438
2,638 New
2,638 $688,000
Q4 2021

Feb 17, 2022

SELL
$177.01 - $223.45 $24,781 - $31,283
-140 Reduced 4.87%
2,737 $601,000
Q3 2021

Dec 03, 2021

SELL
$181.39 - $202.99 $6,348 - $7,104
-35 Reduced 1.2%
2,877 $522,000
Q2 2021

Aug 17, 2021

BUY
$187.49 - $221.1 $14,624 - $17,245
78 Added 2.75%
2,912 $589,000
Q1 2021

May 24, 2021

SELL
$207.02 - $241.31 $182,384 - $212,594
-881 Reduced 23.71%
2,834 $604,000
Q4 2020

Feb 16, 2021

BUY
$207.01 - $276.09 $265,179 - $353,671
1,281 Added 52.63%
3,715 $878,000
Q3 2020

Nov 19, 2020

BUY
$255.65 - $303.1 $622,252 - $737,745
2,434 New
2,434 $662,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Kingsview Wealth Management, LLC Portfolio

Follow Kingsview Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kingsview Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kingsview Wealth Management, LLC with notifications on news.